Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Elena Vega

GLP-1 Weight-Loss Drugs May Be Thinning Bone: Doctors Are Starting to Have This Conversation with Patients

Why This Matters

Tens of millions of Americans are now taking or are about to start a GLP-1 receptor agonist for weight loss, obesity management, or type 2 diabetes. Most are focused on what the drugs do for their weight, blood sugar, and cardiovascular risk. Few are asking what these drugs may be doing to their bones.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.